Bethany Sensenig, Director: Supernus Pharmaceuticals SUPN Planned sale · Filed 02/19

Trade details

Type: Planned sale notice
Stock: Supernus Pharmaceuticals SUPN
Person: Bethany SensenigDirector
Planned sale date: 26/02/19
Filed: 26/02/19

$224.6K to be sold

Supernus Pharmaceuticals trades, last 26 weeks

What else happened in Supernus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/20~03/21

Bethany Sensenig's recent trades

Bethany SensenigDirector
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$167K
3,258 sh
$167K
Filed 02/23
Traded 02/19
Bethany SensenigDirector
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$61.2K
1,217 sh
$61.2K
Filed 02/23
Traded 02/19
Bethany SensenigDirector
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$226.8K
5,369 sh
$226.8K
Filed 25/08/18
Traded 25/08/14
Bethany SensenigDirector
Planned sale10b5-1 planSupernus Pharmaceuticals
Planned sale10b5-1 plan
Supernus Pharmaceuticals
SUPN
$228.9K
5,369 sh
$228.9K
Filed 25/08/14
Traded 25/08/14
Bethany SensenigCFO
Sell9 Meters Biopharma
Sell
9 Meters Biopharma
NMTR
$11K
9,100 sh
$11K
Filed 23/04/21
Traded 23/04/21

Bethany Sensenig, Director — plans to sell 4,475 sh of Supernus Pharmaceuticals SUPN · $224.6K · around 02/19 · 10b5-1 plan | Whalegun